Igc pharma expands holiby(tm) product line with 'longevity' and 'renew' - targeting the multi-billion-dollar anti-aging market

- new science-backed formulations designed to support cellular health, energy metabolism, and cognitive function - potomac, md / access newswire / february 20, 2025 / igc pharma, inc. (nyse american:igc) ("igc pharma" or the "company") is expanding its holiby™ wellness brand with the launch of two new product lines-longevity and renew-specifically designed to meet the increasing demand for anti-aging and cellular health solutions. holiby is scaling its commercial strategy through direct-to-consumer e-commerce, white-label and private-label partnerships, and targeted influencer marketing and digital advertising.
IGC Ratings Summary
IGC Quant Ranking